Drug Database
Back to search

Poland· PL-100215393

Uvadex 20 mikrogramów/ml roztwór do modyfikowania frakcji krwi

A methoxsalen product containing methoxalenum, registered in Poland by Therakos Europe Ltd. The same ATC class is registered in 9 of our 19 countries.

ATC D05BA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedUvadex 20 mikrogramów/ml roztwór do m…ATCD05BA02REGISTER NO.PL-100215393PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about methoxalenumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Methoxsalen is registered in 9 of 19 countries.

Countries holding a registration under ATC D05BA02 (methoxsalen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search methoxsalen products by name

Methoxsalen · ATC D05BA02

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Methoxalenum
Manufacturer
Therakos Europe Ltd
Country
Poland (PL)
ATC code
D05BA02
ATC class
Methoxsalen
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990727421
  • gtin
    05391534989981

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for methoxsalen.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check methoxsalen against other medicinesHow interaction checks work

Methoxsalen · interactions on record

3 records

  • 1 severe
  • 2 moderate

Most severe, free to view

  • Aminolevulinic acidL01XD04severe
  • Porfimer sodiumL01XD01moderate
  • VerteporfinS01LA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methoxsalen in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methoxsalen products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Methoxsalen Macopharma, Methoxsalen S.A.L.F.
  • Belgium · Methoxsalen Macopharma
  • Czechia · Methoxsalen Maco Pharma, Uvadex
  • Germany · Methoxsalen G.L. Pharma, Methoxsalen Macopharma
  • Denmark · Methoxsalen Macopharma, Uvadex
  • Spain · Metoxaleno G. L. Pharma, Metoxaleno Macopharma
  • France · Meladinine, Methoxsalene G.L. Pharma
  • United Kingdom (Northern Ireland) · Methoxsalen G.L. Pharma, Uvadex
  • Greece · Melaoline
  • Hungary · Methoxsalen Macopharma, Uvadex
  • Italy · Metoxsalene G.L. Pharma, Metoxsalene S.A.L.F.
  • Netherlands · Uvadex
  • Norway · Uvadex
  • Portugal · Uvadex
  • Sweden · Uvadex
  • Slovenia · Metoksalen Maco Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ade720b3-b98e-4d1d-875c-1b8790efa272
GET /v1/drugs/ade720b3-b98e-4d1d-875c-1b8790efa272?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do modyfikowania frakcji krwi",
  "source": "urpl",
  "strength": "20 mikrogramów/ml",
  "packaging": "05909990727421 ¦ Lz ¦ Skasowane ¦ 52910\n12 fiol. 10 ml\n05391534989981 ¦ Lz ¦ 159327\n12 fiol. 10 ml",
  "substance": "Methoxsalenum 20 mcg/ml",
  "common_name": "Methoxalenum",
  "pl_product_id": "100215393",
  "pozwolenie_nr": "15861",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about methoxsalen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console